Literature DB >> 21356578

Childhood and adolescent migraine: a neuropsychiatric disorder?

Umberto Balottin1, Matteo Chiappedi, Maura Rossi, Cristiano Termine, Giuseppe Nappi.   

Abstract

Migraine is a neurological disorder characterized by unilateral head pain, nausea and/or vomiting and altered sensory perception (particularly phono- and/or photophobia). It is a common and disabling condition in children and adolescents, just as it is in adults; its origins, pathophysiology and long-term course are still not fully understood. Biological factors are currently held to be crucial in the aetiopathogenesis of primary headaches, such as migraine. In children and adolescents, we hypothesize that for migraine to develop, life events and their psychological processing are fundamental and can act in two different ways: either as a predisposing factor, inducing a chronic state of anxiety or depression (even subclinical), or as a trigger factor, activating a cascade of psychological events which, in turn, activate the biological mechanisms that produce the migraine attack. According to our hypothesis, psychological processing of life events (i.e. how the child perceives and mentally processes them) is the main factor in migraine aetiopathogenesis. This hypothesis has important implications in terms of diagnostic and therapeutic choices for children and adolescents with migraine.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21356578     DOI: 10.1016/j.mehy.2011.02.016

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  16 in total

1.  Accompanying migrainous features in pediatric migraine patients with restless legs syndrome.

Authors:  Melis Sohtaoğlu Sevindik; Seden Demirci; Baki Göksan; Aynur Özge; Feray Karaali Savrun; Hatice Onur; Veli Yıldırım; Ismail Simsek; Harika Ozhan; Derya Uludüz
Journal:  Neurol Sci       Date:  2017-07-01       Impact factor: 3.307

2.  Headache in school age.

Authors:  G Casucci; R Terlizzi; S Cevoli
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

Review 3.  Psychological Therapy in Adolescents with Chronic Daily Headache.

Authors:  Matteo Chiappedi; Martina Maria Mensi; Cristiano Termine; Umberto Balottin
Journal:  Curr Pain Headache Rep       Date:  2016-01

4.  Comorbidity of Migraine, Major Depressive Disorder, and Generalized Anxiety Disorder in Adolescents and Young Adults.

Authors:  Lilian N Dindo; Ana Recober; Rita Haddad; Chadi A Calarge
Journal:  Int J Behav Med       Date:  2017-08

Review 5.  Medication overuse headache in children and adolescents.

Authors:  Matteo Chiappedi; Umberto Balottin
Journal:  Curr Pain Headache Rep       Date:  2014-04

6.  Complete corpus callosum agenesis: can it be mild?

Authors:  Matteo Chiappedi; Anna Fresca; Ilaria Maria Carlotta Baschenis
Journal:  Case Rep Pediatr       Date:  2012-08-29

7.  Self-concept evaluation and migraine without aura in childhood.

Authors:  Maria Esposito; Beatrice Gallai; Lucia Parisi; Laura Castaldo; Rosa Marotta; Serena Marianna Lavano; Giovanni Mazzotta; Michele Roccella; Marco Carotenuto
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-05       Impact factor: 2.570

8.  Psychotherapy versus usual care in pediatric migraine and tension-type headache: a single-blind controlled pilot study.

Authors:  Umberto Balottin; Matteo Ferri; Michela Racca; Maura Rossi; Giorgio Rossi; Ettore Beghi; Matteo Chiappedi; Cristiano Termine
Journal:  Ital J Pediatr       Date:  2014-01-20       Impact factor: 2.638

9.  Migraine and periodic limb movement disorders in sleep in children: a preliminary case-control study.

Authors:  Maria Esposito; Pasquale Parisi; Silvia Miano; Marco Carotenuto
Journal:  J Headache Pain       Date:  2013-07-01       Impact factor: 7.277

10.  Maternal personality profile of children affected by migraine.

Authors:  Maria Esposito; Michele Roccella; Beatrice Gallai; Lucia Parisi; Serena Marianna Lavano; Rosa Marotta; Marco Carotenuto
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-11       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.